SPDR S&P Pharmaceuticals ETF
XPH
XPH
79 hedge funds and large institutions have $337M invested in SPDR S&P Pharmaceuticals ETF in 2015 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 36 increasing their positions, 16 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
1% more funds holding
Funds holding: 78 → 79 (+1)
1.7% less ownership
Funds ownership: 58.97% → 57.27% (-1.7%)
13% less call options, than puts
Call options by funds: $593K | Put options by funds: $679K
Holders
79
Holding in Top 10
2
Calls
$593K
Puts
$679K
Top Buyers
| 1 | +$4.53M | |
| 2 | +$4.26M | |
| 3 | +$3.48M | |
| 4 |
MAA
Managed Account Advisors
Jersey City,
New Jersey
|
+$3.27M |
| 5 |
Jane Street
New York
|
+$3.22M |
Top Sellers
| 1 | -$18.6M | |
| 2 | -$12.8M | |
| 3 | -$5.92M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$5.46M |
| 5 |
Morgan Stanley
New York
|
-$960K |